Showing results (71-80 of 510) with videos related to
Sort By:
Pageof 51
European Journal of Pharmacology|April 24, 1991
Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in ratsL Vécsei, M F BealAnnals of Neurology|June 1, 1988
Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's diseaseM F Beal, M F Mazurek, D W Ellison, et al.Journal of Neural Transmission. Supplementum|August 29, 2000
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative diseaseD S Albers, M F BealMolecular Aspects of Medicine|January 1, 1997
Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseasesM F Beal, R T MatthewsBrain Research|May 8, 1989
Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseasesR A Clevens, M F BealAnnals of Neurology|February 1, 1988
Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's diseaseN W Kowall, M F BealBrain Research|January 20, 1987
Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomesG K Chattha, M F BealAnnals of Neurology|May 19, 2001
Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disordersM A Tarnopolsky, M F BealProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1986
CSF neurotransmitter markers in Alzheimer's diseaseM F Beal, J H GrowdonNeurology|July 1, 1987
Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortexM F Beal, M F MazurekPageof 51